NYSE · CTEV

Claritev Corporation

$21.61 -$1.66 (-7.13%) 1D Market open

Key Metrics

$396.70M
Market cap
P/E · TTM
$978.76M
Revenue · TTM
−$286.52M
Net income
EPS · TTM $-17.61
Dividend yield
Free cash flow −$35.90M
Beta · 1Y 2.18
EBITDA · TTM −$273.63M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    Money has been moving out of its sector (Technology).

    Technology has run -4.1 points vs SPY over four weeks, ranking 8→2→11→7 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 15
    From its May 11 high, the share price fell 53%.

    Peak close $29.65 on May 11; trough close $13.87 on May 15. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -53%
  • May 15
    The stock moved -40.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 15
  • Feb 24
    The stock moved -41.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 24

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$396.70M
Enterprise value$5.01B
Shares outstanding17.0M
52-wk range$11.50 – $74.07
Avg volume · 20D149.2K
Net cash −$4.62B
Book value / share$-14.82
IndustryServices-Business Services, Nec
ExchangeNYSE
About Claritev Corporation
IPO dateApr 3, 2020
Employees3000

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.41
P/FCF
EV/EBITDA
EV/Sales5.12
Graham №

Profitability

Gross
Operating -38.4%
Net -29.3%
FCF -3.7%
ROE / ROIC 364.7% · -6.5%

Financial Health

Current ratio1.28
Quick ratio
Debt / equity-19.24
Debt / EBITDA -16.95
Net cash −$4.62B
Working capital$52.70M

Cash Flow · TTM

Operating CF $101.60M
Capex −$137.50M
Free cash flow −$35.90M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

-0.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings